Anticoagulation Management and Outcomes in Patients with Cancer-Associated Small Venous Thromboembolism – JTH
Journal of Thrombosis and Haemostasis (JTH), shared a post on LinkedIn about a recent article by Claire Kelly, adding:
”Anticoagulation Management and Outcomes in Patients with Cancer-Associated Small Venous Thromboembolism: A Retrospective Cohort Study
In this single-center retrospective study of 268 cancer patients with distal DVT and/or subsegmental PE, recurrent VTE rates at 6 months were substantial – particularly among those not initiated on anticoagulation – highlighting the importance of active thromboprophylactic management in this population.”
Title: Contrary to current guidance, antenatal factor IX levels increase in female carriers of hemophilia B
Authors: Claire Kelly, Janet Cleary, Catriona Keenan, Isabelle Delachapelle, Leona Connolly, Mary Byrne, Mairead O’Donovan, Niamh M. O’Connell, James S. O’Donnell, Kevin Ryan, Michelle Lavin
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 23, 2026, 10:33Johanna Rodríguez: The Structural Challenge of Next-Gen Anticoagulants
-
Jul 23, 2026, 10:27Logan Hamilton: New Study Identifies the Mutated Antibody Gene Responsible for VITT
-
Jul 23, 2026, 09:05Fonkou Steve: What If We’ve Been Asking the Wrong Question About Plasma Too?
-
Jul 23, 2026, 08:27Registration Is Now Open for ASH 2026
-
Jul 23, 2026, 08:19Sheeza Nawaz: Why Do Patients With Aortic Stenosis Bleed?
-
Jul 23, 2026, 07:59Paschalis Karakasis: Can Left Atrial Appendage Closure Truly Replace Oral Anticoagulation?
-
Jul 23, 2026, 06:53Lakmali Silva: What Makes ISTH More Than a Scientific Meeting?
-
Jul 23, 2026, 05:48Paschalis Evangelidis: Rethinking Pulmonary Embolism Through the Lens of Thromboinflammation
-
Jul 23, 2026, 05:35Neil Morgan: Honoured to Lead the Platelet and Megakaryocyte Theme at ISTH 2026